On 12th April 2019, Cuu Long Pharmaceutical Joint Stock Company (DCL) organized 188bet đăng nhập Annual General Meeting of Shareholders (General Meeting of Shareholders) in 2019.
At 188bet đăng nhập congress, shareholders agreed to approve 188bet đăng nhập report of business results 2018 and business plan 2019; audited financial statements of 2018; report of 188bet đăng nhập Supervisory Board on 188bet đăng nhập company’s activities; and some other related papers.
2018 was a volatile year of Vietnam’s pharmaceutical industry as input prices increased sharply, some raw materials increased from 50% to 80%, causing many difficulties, affecting business results 2018 of domestic pharmaceutical enterprises, including DCL. Therefore, 188bet đăng nhập net revenue of DCL in 2018 reached 804.2 billion, up 5% compared to 2017, reaching 83% 188bet đăng nhập plan of 963.2 billion, profit after tax was 12.7 billion. In addition, Euvipharm is still in a period of unstable operation, which has affected DCL’s after-tax profit in 2018. At 188bet đăng nhập meeting, 188bet đăng nhập Board of Directors reported to shareholders about 188bet đăng nhập plan to divest capital at Euvipharm to ensure 188bet đăng nhập general business activities of 188bet đăng nhập pharmaceutical sector as well as ensure benefits for shareholders.
Also according to 188bet đăng nhập report of 188bet đăng nhập Board of Directors, in 2018, 188bet đăng nhập total production output of pharmaceutical factories reached 1.182 million units, completing 94.3% of 188bet đăng nhập plan, down 6% compared to 188bet đăng nhập year 2017. 188bet đăng nhập reason of 188bet đăng nhập decline is because company is restructuring its product portfolio, adjusting production plans, focusing mainly on brand products, high profits, as a premise for developed plan for 188bet đăng nhập following years. 188bet đăng nhập production of capsule is always 188bet đăng nhập advantage of DCL, in 2018, 188bet đăng nhập company has produced 4.586 million capsules reaching 99.73% of 188bet đăng nhập plan and up 22.6% over 188bet đăng nhập same period in 2017. With 188bet đăng nhập third factory started operation in mid-2018 to triple 188bet đăng nhập current capacity, expected to contribute 20% of DCL’s total revenue of 2019. In addition, 188bet đăng nhập medical instrument factory in 2018 achieved 128.3 million products, equivalent to 97.2% of 188bet đăng nhập plan and increased 0.23% compared to 2017. In 2019, DCL is researching Investing in a project to build a new medical material factory with modern technology to contribute to 188bet đăng nhập increasing productivity and maximizing 188bet đăng nhập performance of this segment.
100% Sharehoslders agreed with all content of 188bet đăng nhập meeting
With investment-focused projects, DCL in 2019 will overcome 188bet đăng nhập current difficulties, and start reaping 188bet đăng nhập fruits of 188bet đăng nhập restructuring process, consolidating 188bet đăng nhập governance system and thereby bringing benefits maximum benefit for shareholders. Benovas cancer drug project is gradually completing a visa application and can attend national scale bidding in 2020, contributing to 188bet đăng nhập revenue of this segment.
Therefore, in 2019, 188bet đăng nhập Board of Directors and 188bet đăng nhập Board of Management set a target to achieve 949.5 billion net revenue, and accordingly 188bet đăng nhập gross profit is expected to reach 297.6 billion and profit after tax will be 79,2 billion. According to this plan, besides large projects that are completed and put into operation, DCL will continue to invest in new projects to improve business efficiency. In addition, 188bet đăng nhập company will focus on developing a sales system, training to improve personnel, focusing on building strategic products, having large sales and high profits or different, few product lines and continue to research and develop high-tech product lines.
Mr. Nikhilesh Deshpande – New CEO of DCL giving a short introduction at meeting
Since becoming a member of FIT Group, receiving investment and strategic planning from parent company, DCL has made strong changes, able to implement big potential projects. With continuous efforts, DCL promises to gradually become one of 188bet đăng nhập leading pharmaceutical companies in Vietnam, most appreciated by patients, employees and partners for products. and 188bet đăng nhập most innovative, accessible and caring service, with a mission to connect and improve 188bet đăng nhập lives of 188bet đăng nhập community through optimal health solutions. And 2019 will be an important year when a number of projects are completed and put into operation, expected to contribute significantly to 188bet đăng nhập increase in revenue for 188bet đăng nhập company as well as other major projects that continue to be invested and started 188bet đăng nhập part that sets 188bet đăng nhập foundation for a solid development for 188bet đăng nhập company in 188bet đăng nhập future. In particular, by recruiting 188bet đăng nhập new CEO, Mr. Nikhilesh Deshpande, an Indian, who has more than 18 years of experience holding senior positions at pharmaceutical companies in Vietnam, has shown 188bet đăng nhập determination of 188bet đăng nhập Board of Directors in raising 188bet đăng nhập level and making DCL become one of 188bet đăng nhập big names in Vietnam pharmaceutical market.
